Abbott Laboratories: Driving Value By Scaling Innovations Seeking Alpha Abbott Laboratories: Driving Value By Scaling Innovations. Abbott Labs (ABT) 1 month
Abbott Laboratories: Cardiovascular Disease Has Been A Tailwind, But Things Could Change Seeking Alpha 1 week
How Abbott Labs Is Leaning Into Obesity Treatment, And Taking On Dexcom Investor's Business Daily 2 weeks
Jim Cramer Says Abbott Laboratories (ABT)’s a ‘Great Company’ Despite the Ongoing Lawsuits Insider Monkey 3 weeks
Is Abbott Laboratories (ABT) The Best Among The S&P 500 Dividend Aristocrats According to Hedge Funds? Insider Monkey 4 weeks
I left a big Texas city for a smaller but fast-growing area nearby. I’m saving money and love the tight-knit community. Business Insider 1 month
Abbott Laboratories Stock Could Soar to $143, According to a Wall Street Analyst. Is It a Buy Around $108? The Motley Fool 1 month
Trade Tracker: Karen Firestone buys Abbott Labs, Chemed, Costar Group and sells Home Depot YouTube 1 month
Abbott Laboratories: A Strong Healthcare Stock For Long-Term Dividend Growth Investors Seeking Alpha 1 month
Diversified Business and Strong Fundamentals Make Abbott Laboratories (ABT) Attractive Insider Monkey 2 months
Dexcom (DXCM) Stock Is Plunging on an ‘Execution Miss.’ What Is Really Going On? InvestorPlace 2 months
Here’s Why Aristotle Atlantic’s Core Equity Composite Sold Abbott Laboratories (ABT) Insider Monkey 2 months
Is Abbott Laboratories (ABT) a Good Dividend Growth Stock to Buy and Hold According to Hedge Funds? Insider Monkey 3 months
Abbott Snags U.S. Clearance To Enter The Obesity Arena, Rivaling Dexcom Investor's Business Daily 3 months